Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Operating Expenses | 3,735 | 1,375 | 3,987 | 43 | 0 |
| Operating Income | -3,735 | -1,375 | -3,987 | -43 | N/A |
| Other Income | 50 | 13 | -56 | 0 | 0 |
| Pre-tax Income | -3,685 | -1,362 | -4,043 | -43 | 0 |
| Net Income Continuous | -3,685 | -1,362 | -4,043 | -43 | N/A |
| Net Income | $-3,685 | $-1,362 | $-4,043 | $-43 | $N/A |
| EPS Basic Total Ops | -0.41 | -0.15 | -0.44 | -0.01 | N/A |
| EPS Basic Continuous Ops | -0.41 | -0.14 | -0.43 | -0.01 | N/A |
| EPS Diluted Total Ops | -0.41 | -0.15 | -0.44 | -0.01 | N/A |
| EPS Diluted Continuous Ops | -0.41 | -0.14 | -0.43 | -0.01 | N/A |
| EBITDA(a) | $-3,735 | $-1,375 | $-3,987 | $-43 | $N/A |